111 related articles for article (PubMed ID: 30837409)
21. Management of gastric and duodenal neuroendocrine tumors.
Sato Y; Hashimoto S; Mizuno K; Takeuchi M; Terai S
World J Gastroenterol; 2016 Aug; 22(30):6817-28. PubMed ID: 27570419
[TBL] [Abstract][Full Text] [Related]
22. Role of proton pump inhibitors in preventing hypergastrinemia-associated carcinogenesis and in antagonizing the trophic effect of gastrin.
Han YM; Park JM; Kangwan N; Jeong M; Lee S; Cho JY; Ko WJ; Hahm KB
J Physiol Pharmacol; 2015 Apr; 66(2):159-67. PubMed ID: 25903947
[TBL] [Abstract][Full Text] [Related]
23. Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?
Scherübl H; Cadiot G; Jensen RT; Rösch T; Stölzel U; Klöppel G
Endoscopy; 2010 Aug; 42(8):664-71. PubMed ID: 20669078
[TBL] [Abstract][Full Text] [Related]
24. Deletion of
Sundaresan S; Kang AJ; Hayes MM; Choi EK; Merchant JL
Gut; 2017 Jun; 66(6):1012-1021. PubMed ID: 26860771
[TBL] [Abstract][Full Text] [Related]
25. Review article: the investigation and management of gastric neuroendocrine tumours.
Basuroy R; Srirajaskanthan R; Prachalias A; Quaglia A; Ramage JK
Aliment Pharmacol Ther; 2014 May; 39(10):1071-84. PubMed ID: 24628514
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological features of primary gastric neuroendocrine neoplasms: A single-center analysis.
Xu TM; Wang CS; Jia CW; Qian JM; Li JN
J Dig Dis; 2016 Mar; 17(3):162-8. PubMed ID: 26860897
[TBL] [Abstract][Full Text] [Related]
27. Neuroendocrine neoplasms of the stomach.
Louthan O
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):455-60. PubMed ID: 23817299
[TBL] [Abstract][Full Text] [Related]
28. Neuroendocrine carcinoma of the gastric stump: A case report and literature review.
Ma FH; Xue LY; Chen YT; Xie YB; Zhong YX; Xu Q; Tian YT
World J Gastroenterol; 2018 Jan; 24(4):543-548. PubMed ID: 29398875
[TBL] [Abstract][Full Text] [Related]
29. The gastric mucosa 25 years after proximal gastric vagotomy.
Sagatun L; Jianu CS; Fossmark R; Mårvik R; Nordrum IS; Waldum HL
Scand J Gastroenterol; 2014 Oct; 49(10):1173-80. PubMed ID: 25157752
[TBL] [Abstract][Full Text] [Related]
30. A prospective evaluation of the effect of chronic proton pump inhibitor use on plasma biomarker levels in humans.
Raines D; Chester M; Diebold AE; Mamikunian P; Anthony CT; Mamikunian G; Woltering EA
Pancreas; 2012 May; 41(4):508-11. PubMed ID: 22460728
[TBL] [Abstract][Full Text] [Related]
31. The cytoprotective protein clusterin is overexpressed in hypergastrinemic rodent models of oxyntic preneoplasia and promotes gastric cancer cell survival.
Vange P; Bruland T; Doseth B; Fossmark R; Sousa MML; Beisvag V; Sørdal Ø; Qvigstad G; Waldum HL; Sandvik AK; Bakke I
PLoS One; 2017; 12(9):e0184514. PubMed ID: 28902909
[TBL] [Abstract][Full Text] [Related]
32. [A clinico-pathological study of neuroendocrine tumors in stomach].
Yu J; Wang L; Wang J; Meng Y; Hu M; Zheng J
Zhonghua Bing Li Xue Za Zhi; 1999 Feb; 28(1):20-3. PubMed ID: 11869506
[TBL] [Abstract][Full Text] [Related]
33. Usefulness of laparoscope-assisted antrectomy for gastric carcinoids with hypergastrinemia.
Hoshino M; Omura N; Yano F; Tsuboi K; Matsumoto A; Yamamoto SR; Akimoto S; Kashiwagi H; Yanaga K
Hepatogastroenterology; 2010; 57(98):379-82. PubMed ID: 20583448
[TBL] [Abstract][Full Text] [Related]
34. Expression of the Cholecystokinin-B Receptor in Neoplastic Gastric Cells.
Mjønes P; Nordrum IS; Sørdal Ø; Sagatun L; Fossmark R; Sandvik A; Waldum HL
Horm Cancer; 2018 Feb; 9(1):40-54. PubMed ID: 28980157
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic aspects of gastric neuroendocrine tumors.
Rindi G
Am J Surg Pathol; 1995; 19 Suppl 1():S20-9. PubMed ID: 7762736
[TBL] [Abstract][Full Text] [Related]
36. A case of mixed adenoneuroendocrine carcinoma of the stomach with focal intestinal metaplasia and hypergastrinemia.
Yamauchi H; Sakurai S; Nakazawa N; Yoshida T; Tabe Y; Saitoh K; Fukasawa T; Kiriyama S; Naitoh H; Kuwano H
Int Surg; 2015 Mar; 100(3):562-7. PubMed ID: 25785345
[TBL] [Abstract][Full Text] [Related]
37. [Consensus and controversy on subtype classification of gastric neuroendocrine neoplasms].
Tan H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):977-981. PubMed ID: 28900986
[TBL] [Abstract][Full Text] [Related]
38. Hypergastrinemia in Long-Term Use of Proton Pump Inhibitors.
Shiotani A; Katsumata R; Gouda K; Fukushima S; Nakato R; Murao T; Ishii M; Fujita M; Matsumoto H; Sakakibara T
Digestion; 2018; 97(2):154-162. PubMed ID: 29310112
[TBL] [Abstract][Full Text] [Related]
39. Gastric metastasis of pancreatic neuroendocrine tumor 5 years after surgical resection of the primary lesion.
Ito T; Inokuma T
Dig Endosc; 2015 Nov; 27(7):781. PubMed ID: 26257244
[No Abstract] [Full Text] [Related]
40. Antiulcer drugs and gastric cancer.
Waldum HL; Gustafsson B; Fossmark R; Qvigstad G
Dig Dis Sci; 2005 Oct; 50 Suppl 1():S39-44. PubMed ID: 16184420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]